These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 2427810)

  • 1. Reduction of reperfusion arrhythmias in the ischemic isolated rat heart by angiotensin converting enzyme inhibitors: a comparison of captopril, enalapril, and HOE 498.
    van Gilst WH; de Graeff PA; Wesseling H; de Langen CD
    J Cardiovasc Pharmacol; 1986; 8(4):722-8. PubMed ID: 2427810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Captopril reduces purine loss and reperfusion arrhythmias in the rat heart after coronary artery occlusion.
    Van Gilst WH; De Graeff PA; Kingma JH; Wesseling H; De Langen CD
    Eur J Pharmacol; 1984 Apr; 100(1):113-7. PubMed ID: 6373306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentration-dependent protection by captopril against ischemia-reperfusion injury in the isolated rat heart.
    De Graeff PA; Van Gilst WH; De Langen CD; Kingma JH; Wesseling H
    Arch Int Pharmacodyn Ther; 1986 Apr; 280(2):181-93. PubMed ID: 3521515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection.
    Grover GJ; Sleph PG; Dzwonczyk S; Wang P; Fung W; Tobias D; Cushman DW
    J Pharmacol Exp Ther; 1991 Jun; 257(3):919-29. PubMed ID: 1646329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological properties of the new orally active angiotensin converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl] -(1S,3S,5S)-2-azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498).
    Becker RH; Schölkens BA; Metzger M; Schulze KJ
    Arzneimittelforschung; 1984; 34(10B):1411-6. PubMed ID: 6097267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential influences of angiotensin converting-enzyme inhibitors on the coronary circulation.
    van Gilst WH; Scholtens E; de Graeff PA; de Langen CD; Wesseling H
    Circulation; 1988 Jun; 77(6 Pt 2):I24-9. PubMed ID: 3286044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Captopril-induced increase in coronary flow: an SH-dependent effect on arachidonic acid metabolism?
    van Gilst WH; van Wijngaarden J; Scholtens E; de Graeff PA; de Langen CD; Wesseling H
    J Cardiovasc Pharmacol; 1987; 9 Suppl 2():S31-6. PubMed ID: 2441198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparisons of effects of Hoe-498 and enalapril in isolated guinea pig hearts and rat myocardium].
    Xiang JZ; Schölkens BA; Linz W; Unger T; Ganten D; Lang RE
    Zhongguo Yao Li Xue Bao; 1985 Jun; 6(2):96-9. PubMed ID: 3002124
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).
    Cushman DW; Wang FL; Fung WC; Grover GJ; Harvey CM; Scalese RJ; Mitch SL; DeForrest JM
    Br J Clin Pharmacol; 1989; 28 Suppl 2(Suppl 2):115S-130S; discussion 130S-131S. PubMed ID: 2557876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of angiotensin converting enzyme by 2-[N-[(S)-1-carboxy-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2-azabicyclo [3.3.0]octane-3-carboxylic acid (Hoe 498 diacid). Comparison with captopril and enalaprilat.
    Bünning P
    Arzneimittelforschung; 1984; 34(10B):1406-10. PubMed ID: 6097266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of converting enzyme in the cerebrospinal fluid of rats after oral treatment with converting enzyme inhibitors.
    Gohlke P; Urbach H; Schölkens B; Unger T
    J Pharmacol Exp Ther; 1989 May; 249(2):609-16. PubMed ID: 2542535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S) -2-azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498)--a new and highly effective angiotensin I converting enzyme inhibitor.
    Metzger H; Maier R; Sitter C; Stern HO
    Arzneimittelforschung; 1984; 34(10B):1402-6. PubMed ID: 6097265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the thromboxane synthetase inhibitor HOE 944, prostacyclin and indomethacin on reperfusion arrhythmias, cardiodynamics and metabolism in isolated ischemic rat hearts.
    Linz W; Lau HH; Beck G; Schökens BA
    Biomed Biochim Acta; 1988; 47(10-11):S23-6. PubMed ID: 3073762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of the converting enzyme inhibitor, ramipril, in ischemic rat hearts.
    Linz W; Schölkens BA; Han YF
    J Cardiovasc Pharmacol; 1986; 8 Suppl 10():S91-9. PubMed ID: 2438498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Are the radical scavenging properties of ACE inhibitors with sulfhydryl groups in therapeutically effective concentrations of quantitative significance?].
    Becker BF; Reinholz N; Leipert B; Raschke P; Gerlach E
    Klin Wochenschr; 1991; 69 Suppl 24():6-9. PubMed ID: 1650863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the converting enzyme inhibitors Hoe 498, enalapril and captopril on vascular reactivity of isolated arterial preparations.
    Schölkens BA; Xiang JZ; Tilly H
    Clin Exp Hypertens A; 1984; 6(10-11):1807-13. PubMed ID: 6099766
    [No Abstract]   [Full Text] [Related]  

  • 17. Unchanged pressor effect of norepinephrine in normal man following the oral administration of two angiotensin converting enzyme inhibitors, captopril and HOE 498.
    Vierhapper H; Witte PU; Waldhäusl W
    J Hypertens; 1986 Feb; 4(1):9-11. PubMed ID: 3007605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of the dipeptidyl peptidase inhibitors captopril, ramipril, and enalapril on water intake and sodium appetite of Sprague-Dawley rats.
    Rowland NE; Fregly MJ
    Behav Neurosci; 1988 Dec; 102(6):953-60. PubMed ID: 2850816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential antiplatelet effects of angiotensin converting enzyme inhibitors: comparison of ex vivo platelet aggregation in cardiovascular patients with ramipril, captopril and enalapril.
    Skowasch D; Viktor A; Schneider-Schmitt M; Lüderitz B; Nickenig G; Bauriedel G
    Clin Res Cardiol; 2006 Apr; 95(4):212-6. PubMed ID: 16598590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does captopril attenuate reperfusion-induced myocardial dysfunction by scavenging free radicals?
    Westlin W; Mullane K
    Circulation; 1988 Jun; 77(6 Pt 2):I30-9. PubMed ID: 2836109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.